Both in Pharmaceuticals
Janux Therapeutics vs Maravai LifeSciences Holdings
Over the past year JANX returned −32.7% and MRVI returned +169.0%; their daily moves had a correlation of 0.10.
JANX −32.7% MRVI +169.0%Growth of $1, one year, split-adjusted
| Metric | JANX | MRVI |
|---|---|---|
| Price | $18.18 | $7.72 |
| Market cap | $1.11B | $1.15B |
| Today | +2.02% | +3.62% |
| 1 month | +8.3% | −1.7% |
| 6 months | +24.4% | +95.9% |
| Year to date | +31.7% | +137.5% |
| 1 year | −33.6% | +162.6% |
| Revenue growth (YoY) | — | +8.5% |
| Gross margin | 100.0% | 40.1% |
| Net margin | −214.0% | −24.1% |
| P/E (TTM) | — | — |
| Price / sales | 46.3× | 5.5× |
| Net cash | $970.9M | -$106.6M |
| Dividend yield | — | — |
| Volatility (60d) | 47.8% | 86.3% |
| Short % of float | 11.8% | 10.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).